APA (7th ed.) Citation

Wong, D. F., Chand, G. B., Caito, N., Eramo, A., Grattan, V. T., Hixon, M. S., . . . Vaino, A. R. (2025). PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement. Neuropsychopharmacology, 50(2), . https://doi.org/10.1038/s41386-024-01951-x

Chicago Style (17th ed.) Citation

Wong, Dean F., et al. "PET Clinical Study of Novel Antipsychotic LB-102 Demonstrates Unexpectedly Prolonged Dopamine Receptor Target Engagement." Neuropsychopharmacology 50, no. 2 (2025). https://doi.org/10.1038/s41386-024-01951-x.

MLA (9th ed.) Citation

Wong, Dean F., et al. "PET Clinical Study of Novel Antipsychotic LB-102 Demonstrates Unexpectedly Prolonged Dopamine Receptor Target Engagement." Neuropsychopharmacology, vol. 50, no. 2, 2025, https://doi.org/10.1038/s41386-024-01951-x.